Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.
A review of sentinel laboratory performance: identification and notification of bioterrorism agents.
Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus.
Identification of genetic variants associated with capecitabine-induced hand-foot syndrome through integration of patient and cell line genomic analyses.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.
A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469. Pharmacogenet Genomics. 2014 Feb; 24(2):129-32.
View in:
PubMed
subject areas
Aldehyde Oxidase
Antineoplastic Agents
Clinical Trials, Phase I as Topic
Cohort Studies
Genetic Variation
Genotype
Humans
Liver
Neoplasms
Pharmacogenetics
Polymorphism, Single Nucleotide
Quantitative Trait Loci
Quinoxalines
authors with profiles
Wendy Stock
Mark J. Ratain